Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Malta David Braga | M | - |
LiMM Therapeutics SA
 LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | - |
| Maria Brandão de Vasconcelos | F | - |
StemCell2MAX
 StemCell2MAX Miscellaneous Commercial ServicesCommercial Services StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal. | 9 Jahre |
| Filipa Matos Baptista | M | - |
StemCell2MAX
StemCell2MAX Miscellaneous Commercial ServicesCommercial Services StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal. | 9 Jahre |
| Diogo Fonseca-Pereira | M | - |
StemCell2MAX
StemCell2MAX Miscellaneous Commercial ServicesCommercial Services StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal. | 9 Jahre |
| Sílvia Arroz-Madeira | F | - |
StemCell2MAX
StemCell2MAX Miscellaneous Commercial ServicesCommercial Services StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal. | 9 Jahre |
| Isabelle de Cremoux | F | 54 |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | - |
| Eric Forquenot de la Fortelle | M | - |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | 6 Jahre |
| Mizrahi Jacques | M | 70 |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | - |
| Eric Forquenot de la Fortelle | M | - |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Frankreich | 5 | 55,56% |
| Portugal | 4 | 44,44% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Fernandes Henrique Veiga
- Persönliches Netzwerk
